AIM logo
Alcohol in
Moderation
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • Cognitive decline
  • Parkinsons' disease& alcohol
  • Arthritis& alcohol
  • Stroke
  • Women& alcohol
    • Breast cancer
    • Pregnancy
Choose a Topic
June 2026
Parkinsons' disease

Early alcohol initiation and Parkinson’s disease risk

Observational evidence linking alcohol consumption to Parkinson’s disease (PD) is inconsistent, possibly because conventional analyses do not account for the long latency between alcohol initiation and clinical onset or diagnosis. A study investigated whether latency-aware modelling altered alcohol-PD associations and whether earlier initiation increased lifetime risk.
Researchers analysed data from two large community studies in Taiwan to examine the long-term relationship between alcohol consumption and Parkinson’s disease (PD). Traditional statistical methods suggested that drinkers had a lower risk of PD. However, when the long delay between alcohol exposure and disease development was accounted for, alcohol use was linked to a higher risk of PD. The increased risk appeared decades after drinking began and was greatest among those who started drinking at a younger age. Smoking appeared to shorten the time between alcohol exposure and the onset of PD. Results from the second, larger study supported these findings, showing that Parkinson’s disease occurred more often in drinkers than non-drinkers, particularly at older ages.
When the timing of alcohol use and the long delay between exposure and disease development were taken into account, the previously observed suggestion that alcohol might be protective disappeared. Instead, the findings indicated that alcohol use was associated with a higher lifetime risk of developing Parkinson’s disease (PD), especially among people who started drinking at a younger age. These results suggest that considering the timing of alcohol exposure and the long-term effects of drinking may provide a more accurate understanding of how alcohol influences Parkinson’s disease risk and could help guide future prevention efforts.
Source: Chang, J.-.C, Yen, A.M.-F., Chen, S.L.-S., Liou, H.-.H, & Chen, T.H.-H. (2026) Early alcohol initiation is associated with higher lifetime Parkinson’s disease risk after accounting for exposure latency. Journal of Parkinson’s Disease.

https://doi.org/10.1177/1877718X261453796
Drinking & You logo
Drinking & You
A global portal providing advice about responsible alcohol consumption, individual country government guidelines and your health.
Go to website
International Scientific Forum on Alcohol Research logo
International Scientific Forum on Alcohol Research
The International Scientific Forum on Alcohol Research (ISFAR) is a group of 45 specialist Professors and Medics who produce balanced and well researched analysis of emerging research papers alcohol and health.
Go to website

To receive notification of updates to the website, please subscribe here

Name(Required)

Topics

Harmful consumption

& alcohol

Healthy lifestyle

& alcohol

Genetics

& alcohol

Depression

& alcohol

Mental health

& alcohol

All-cause mortality

& alcohol

Cancer

& alcohol

Diabetes

& alcohol

Heart

& alcohol

Antioxidants

& alcohol

Bone mineral density

& alcohol

The brain

& alcohol

General health

& alcohol

Gut health

& alcohol

J-shaped curve

& alcohol

The kidneys

& alcohol

The liver

& alcohol

Mediterranean diet

& alcohol

Metabolic syndrome/weight

& alcohol

Moderate drinking

Old age

& alcohol

Parkinsons' disease

& alcohol

Arthritis

& alcohol

Stroke

& alcohol

Women

& alcohol

Methodology

& alcohol

Latest articles

Associations between beer, wine, and spirits consumption and major mortality outcomes in Norwegian men and women

Alcohol consumption and dementia risk in steatotic liver disease: a nationwide cohort study

A large randomised trial assessing alcohol cessation versus moderation on clinical events: UNATI

The impact of alcohol consumption on bone mineral density

Alcohol consumption and the risks of morbidity and mortality across 39 diseases and conditions

Aim Digest

October 2026

September 2026

June 2026

May 2026

April 2026

© Alcohol In Moderation, 2026.
Web design by Rubber Duckers
Close menu
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
Close menu
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • ← Back
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • ← Back
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • ← Back
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • ← Back
    • Cognitive decline
  • Parkinsons' disease& alcohol
  • Arthritis& alcohol
  • Stroke
  • Women& alcohol
    • ← Back
    • Breast cancer
    • Pregnancy